Corient Private Wealth’s Seagen Inc. Common Stock SGEN Stock Holding History

Corient Private Wealth’s Portfolio SGEN Stock Details SGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-7,564	Closed	-$1.61M	–	2372
2023 Q3	$1.61M	Buy	7,564 +2,557	+51%	+$511K	﹤0.01%	995
2023 Q2	$964K	Sell	5,007 -3,062	-38%	-$608K	﹤0.01%	1168
2023 Q1	$1.63M	Buy	8,069 +4,573	+131%	+$733K	﹤0.01%	914
2022 Q4	$453K	Buy	+3,496	New	+$451K	﹤0.01%	1173

Other funds holding SGEN

SCM

Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

FBC

Fairfield, Bush & Co Darien, Connecticut $203M AUM 38.37% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

SAG

Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return

Corient Private Wealth's SGEN Position: Q4 2023 in Review

Corient Private Wealth sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 7,564 shares — an estimated $1.61M sold.

Corient Private Wealth first reported a position in SGEN in Q4 2022 and held it in 4 quarters. The position peaked at $1.63M in Q1 2023. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

Corient Private Wealth reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Corient Private Wealth sold 7,564 Seagen Inc. Common Stock shares in Q4 2023, an estimated $1.61M.
Corient Private Wealth first reported a position in Seagen Inc. Common Stock in Q4 2022 and held it in 4 quarters.
Corient Private Wealth's Seagen Inc. Common Stock position peaked at $1.63M in Q1 2023.
6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on Corient Private Wealth's 13F filing for Q4 2023, filed 9 Feb 2024.